Bioceptive is a health company focused on developing innovative medical devices for gynecological procedures. The company primarily serves healthcare providers, including gynecologists and primary care physicians, who perform intrauterine device (IUD) insertions. Operating in the medical device market, Bioceptive aims to improve the safety and accessibility of gynecological procedures through its advanced platform technology.

Bioceptive's core product is a novel IUD insertion system that replaces the traditional cervical tenaculum with a gentler, suction-based device. This new approach minimizes trauma and bleeding during the procedure, making it less painful and more intuitive for both patients and healthcare providers. The disposable version of this device has received FDA 510k clearance and has successfully completed clinical trials, while the reusable version is currently undergoing testing.

The company's business model revolves around the commercialization of these medical devices. Revenue is generated through the sale of both disposable and reusable versions of the IUD insertion system. By offering a more user-friendly and less traumatic insertion method, Bioceptive aims to democratize access to IUDs, potentially expanding their use worldwide.

Keywords: gynecological devices, IUD insertion, cervical tenaculum, suction-based device, FDA clearance, clinical trials, healthcare providers, trauma-free, medical innovation, commercialization.